February 28th, 2020: “EURETINA-Brief”© Issue No. 208

by Dr. Gearóid Tuohy

 

 

Dear EURETINA Members,

 

A very warm welcome to the February 28th, 2020 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”.  EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is designed to accommodate the very busy schedules of all our members by providing them with a short overview of some new developments and announcements in our field over recent weeks.

 

As in previous issues we have incorporated a feedback section where you can comment on any of the news items or articles under discussion and we very much welcome all contributions.  Previous articles and issues can be found in the archive section on this website.

 

The current issue highlights a number of research activities, clinical / regulatory milestones, and market / business developments in our field, including a study from an Israeli research consortium that has reported the largest nationwide genetic analysis of inherited retinal disease; a clinical report on non-compliance in clinical trials of retinal studies that may show a significant loss-to-follow up on patient numbers, and reports that have identified concerns for medical complications from Novartis’ brolucizumab (Beovu) product for wet AMD.

 

As always, your increased interaction within the EURETINA web community serves to expand your professional network and keep you up to date with the latest initiatives, activities and research in your field. Our hope is that such cross-fertilisation in an active web-based platform, including our LinkedIn page, will lead to increased collaborative opportunities and ultimately to improved patient care. All readers are invited to submit comments or responses to any of the stories featured and we look forward to hearing from you over the coming month.

 

 

Best wishes,

Dr. Gearóid Tuohy, EURETINA

14 thoughts on “February 28th, 2020: “EURETINA-Brief”© Issue No. 208”

  1. Magnificent beat ! I would like to apprentice even as you amend your site, how
    can i subscribe for a blog site? The account helped me
    a appropriate deal. I had been a little bit acquainted of this
    your broadcast provided shiny clear idea

  2. It is perfect time to make some plans for the future and it’s time to be happy.
    I’ve read this post and if I could I wish to suggest you few interesting things
    or suggestions. Maybe you could write next articles referring
    to this article. I desire to read even more things about it!

  3. Interesting blog! Is your theme custom made or did you download it from somewhere?
    A design like yours with a few simple tweeks would really make my
    blog shine. Please let me know where you got your design. Cheers

  4. Excellent site you have here but I was wanting to know if you knew of any user discussion forums that cover the same topics discussed
    in this article? I’d really like to be a
    part of online community where I can get advice from other
    experienced people that share the same interest. If you have any recommendations, please
    let me know. Thanks!

  5. Hi, Neat post. There’s an issue along with your site in internet explorer, would check this?
    IE still is the marketplace leader and a big element of other folks will omit your
    excellent writing due to this problem.

  6. I simply want to say I’m very new to blogs and truly liked your web-site. More than likely I’m want to bookmark your site . You certainly have amazing stories. Cheers for sharing your web site.

  7. Interesting website, i read it but i still have a few questions. shoot me an email and we will talk more becasue i may have an interesting idea for you.

Leave a Reply

Your email address will not be published.